Rithem Life Sciences

Executive Summary

Rithem Life Sciences is a San Diego-based medical device company focused on improving survival rates from sudden cardiac arrest. Founded in 2020, the company has developed two innovative products: a personal CPR device designed to guide effective at-home resuscitation and a portable automated external defibrillator (AED) for rapid emergency response. These devices address a critical gap in out-of-hospital cardiac arrest care, where every minute counts. The personal CPR device provides real-time feedback to users, ensuring proper chest compression depth and rate, while the AED offers user-friendly operation for bystanders with minimal training. Together, they form a comprehensive solution for layperson responders. Despite being early-stage, Rithem Life Sciences is positioned in a growing market driven by regulatory mandates for AED accessibility and increasing awareness of bystander CPR. The company's products have the potential to save thousands of lives annually by empowering individuals to act confidently during cardiac emergencies.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation AED70% success
• Q3 2026Strategic partnership with a national CPR training organization50% success
• TBDClinical study results demonstrating improved survival outcomes40% success